Novo Nordisk to slash U.S. insulin prices, following move by Eli Lilly
The Danish drugmaker will reduce the list price of its NovoLog insulin by 75%, and for Novolin and Levemir by 65%.
Public health & disease
Breakthrough drug works against all the main types of primary bone cancer
The drug, developed by researchers at the U.K.’s University of East Anglia, increases survival rates by 50% without the need for surgery or chemotherapy.
Remnants of two banned insecticides nearly eliminated in Great Lakes region
In 2006, the U.S. EPA banned the agricultural use of lindane, linked to anemia, lung cancer, and lymphoma. In 2010, it began to phase out endosulfan, which experts say may damage the liver and kidneys.
Researchers cure toddler of deadly metachromatic leukodystrophy (MLD) for first time in history
A British girl born with a rare and deadly genetic condition is expected to live a long and normal life after becoming the world’s first person to be cured with the help of a revolutionary gene therapy.
Eli Lilly caps the cost of insulin in the U.S. at $35 a month
Insulin costs in the U.S. are notoriously high compared to the costs in other countries; the Rand Corporation, a public policy think tank, estimated that in 2018, the average list price for one vial of insulin in the U.S. was $98.70.
REI to stop selling clothes, cookware with ‘forever chemicals’
REI aims to have all cookware and apparel sold in its stores free of PFAS by fall of 2024. PFAS have been linked to cancer and other health problems.
Brazil moves to oust illegal miners from Indigenous lands in the Amazon
The invasion of miners has contributed to the spread of malaria among the Yanomami, with devastating consequences
German man becomes third human to be completely cured of HIV
Like the “Berlin patient” and the “London patient” before him, the “Düsseldorf patient” received treatment for an acute blood disease and, in the process, was cured of HIV infection.
Guinea worm is on the brink of becoming the second human disease in history to be eradicated
A painful, parasitic disease that once infected 3.5 million people per year is tantalizingly In 2022, just 12 cases were record worldwide.
Australia becomes world’s first country to officially recognize psychedelics as medicines
MDMA and psilocybin will be available for controlled use to address PTSD and depression when prescribed by a psychiatrist starting in July 2023.